P2BH34 Stock Overview
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Prestige Consumer Healthcare Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$60.45 |
| 52 Week High | US$0 |
| 52 Week Low | US$0 |
| Beta | 0.44 |
| 11 Month Change | -0.46% |
| 3 Month Change | 1.80% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -2.01% |
Recent News & Updates
Recent updates
Shareholder Returns
| P2BH34 | BR Pharmaceuticals | BR Market | |
|---|---|---|---|
| 7D | 0% | 1.8% | 2.5% |
| 1Y | n/a | -23.6% | -1.4% |
Return vs Industry: Insufficient data to determine how P2BH34 performed against the BR Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how P2BH34 performed against the BR Market.
Price Volatility
| P2BH34 volatility | |
|---|---|
| P2BH34 Average Weekly Movement | 3.1% |
| Pharmaceuticals Industry Average Movement | 4.5% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in BR Market | 9.3% |
| 10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: P2BH34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine P2BH34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 560 | Ron Lombardi | www.prestigebrands.com |
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief.
Prestige Consumer Healthcare Inc. Fundamentals Summary
| P2BH34 fundamental statistics | |
|---|---|
| Market cap | R$15.02b |
| Earnings (TTM) | -R$402.31m |
| Revenue (TTM) | R$5.55b |
2.8x
P/S Ratio-37.9x
P/E RatioIs P2BH34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| P2BH34 income statement (TTM) | |
|---|---|
| Revenue | US$1.13b |
| Cost of Revenue | US$500.48m |
| Gross Profit | US$626.54m |
| Other Expenses | US$708.30m |
| Earnings | -US$81.77m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Feb 08, 2024
| Earnings per share (EPS) | -1.65 |
| Gross Margin | 55.59% |
| Net Profit Margin | -7.26% |
| Debt/Equity Ratio | 82.2% |
How did P2BH34 perform over the long term?
See historical performance and comparison